"Bring Your Own Device"-A New Approach to Wearable Outcome Assessment in Trauma
Benedikt J Braun1, Tina Histing1, Maximilian M Menger1
1Department of Trauma and Reconstructive Surgery, Eberhard-Karls-University Tuebingen, BG Unfallklinik, 72076 Tuebingen, Germany.
Medicina (Kaunas, Lithuania)
|February 25, 2023
Summary
Utilizing patients' own wearable devices, known as the Bring Your Own Device (BYOD) strategy, is a feasible method for collecting continuous outcome data in trauma patients. This approach allows for baseline measures and demonstrates achievable recovery patterns.
Area of Science:
- Digital Health
- Wearable Technology in Medicine
- Musculoskeletal Injury Research
Background:
- Wearable device data is increasingly vital for research and clinical outcomes.
- Traditional methods use dedicated devices, limiting baseline and achievable outcome data.
- A novel Bring Your Own Device (BYOD) strategy is proposed.
Purpose of the Study:
- To explore the feasibility of using patients' own wearable devices for outcome measurement.
- To establish a pre-injury baseline and assess achievable recovery results.
- To analyze activity data patterns in patients with musculoskeletal injuries.
Main Methods:
- An exploratory, proof-of-concept study involving patients with upper and lower extremity musculoskeletal injuries.
- Continuous acquisition of wearable outcome data (smartphone/body sensor) for at least 6 weeks post-injury.
- Descriptive analysis of screening characteristics and observed/achievable outcome patterns.
Main Results:
- 432 patients were screened; 48 were included in the analysis, with higher inclusion rates in younger patients.
- Step count was the most common outcome measure.
- Three distinct activity patterns emerged: recovery, slow/no recovery, and needing further assessment.
Conclusions:
- The Bring Your Own Device (BYOD) strategy is feasible for measuring outcomes in trauma patients.
- This method provides continuous activity data without requiring dedicated equipment.
- The BYOD approach is particularly suitable for specific patient cohorts and can inform future study designs.


